Related Experiment Video
Updated: Aug 8, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
HIV-1 dynamics in children
A J Melvin1, A G Rodrigo, K M Mohan
1Department of Pediatrics, University of Washington, Seattle, USA. ajmelvin@u.washington.edu
Pediatric HIV-1 infection shows faster disease progression. Viral dynamics during highly active antiretroviral therapy (HAART) reveal slower viral decay in children compared to adults, suggesting unique treatment needs.
Area of Science:
- Virology
- Pediatric Infectious Diseases
- Immunology
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) infection in children typically presents with higher viral loads and more rapid disease progression than in adults.
- Understanding the distinct viral dynamics in pediatric HIV-1 is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To investigate and compare the viral dynamics of HIV-1 in children undergoing highly active antiretroviral therapy (HAART) with those previously reported in adults.
- To elucidate potential differences in HIV-1 pathogenesis and treatment responses between pediatric and adult populations.
Main Methods:
- Measurement of viral dynamics, specifically plasma HIV-1 RNA levels, following the initiation of HAART in pediatric patients.
- Analysis of biphasic viral decline (Phase I and Phase II) and calculation of decay rates and half-lives.
- Comparison of pediatric viral decay rates with established adult data.
Main Results:
- A biphasic decline in plasma HIV-1 RNA was observed in children during HAART.
- Phase I decay rates in children were comparable to those in adults.
- Phase II decay rates were significantly slower in children (mean half-life 43.3 days) compared to adults (mean half-life 14.1 days).
- The time to reach undetectable viral levels was longer in children than in adults.
Conclusions:
- HIV-1 viral dynamics differ between children and adults, particularly during the later phase of antiretroviral therapy.
- The slower viral clearance in children suggests potential differences in viral replication or drug penetration/efficacy.
- These findings highlight the need for tailored or modified treatment strategies for pediatric HIV-1 infection.
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Size and Structure of Viral Genomes
Cytomegalovirus Disease
Inhibitors of Virion Maturation and Assembly

